CME Group Inc. $CME Shares Purchased by ABN Amro Investment Solutions

ABN Amro Investment Solutions increased its stake in CME Group Inc. (NASDAQ:CME) by 8.2% in the 1st quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 33,360 shares of the financial services provider’s stock after acquiring an additional 2,523 shares during the quarter. ABN Amro Investment Solutions’ holdings in CME Group were worth $9,853,000 at the end of the most recent reporting period.

A number of other large investors also recently added to or reduced their stakes in the stock. Norges Bank acquired a new position in shares of CME Group during the fourth quarter valued at approximately $1,523,241,000. Victory Capital Management Inc. boosted its stake in shares of CME Group by 746.4% in the fourth quarter. Victory Capital Management Inc. now owns 2,049,649 shares of the financial services provider’s stock worth $559,720,000 after acquiring an additional 1,807,491 shares during the last quarter. Life Cycle Investment Partners Ltd purchased a new stake in shares of CME Group during the fourth quarter worth approximately $217,656,000. Viking Global Investors LP purchased a new stake in shares of CME Group during the second quarter worth approximately $164,648,000. Finally, Vanguard Group Inc. raised its stake in CME Group by 1.7% in the 4th quarter. Vanguard Group Inc. now owns 35,895,583 shares of the financial services provider’s stock valued at $9,802,366,000 after purchasing an additional 588,509 shares during the last quarter. 87.75% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at CME Group

In related news, insider Hilda Harris Piell sold 5,753 shares of the firm’s stock in a transaction dated Monday, May 18th. The stock was sold at an average price of $304.63, for a total transaction of $1,752,536.39. Following the completion of the sale, the insider directly owned 27,702 shares of the company’s stock, valued at approximately $8,438,860.26. This trade represents a 17.20% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director William R. Shepard acquired 325 shares of CME Group stock in a transaction that occurred on Thursday, June 25th. The stock was bought at an average price of $230.57 per share, for a total transaction of $74,935.25. Following the completion of the acquisition, the director owned 260,442 shares in the company, valued at $60,050,111.94. This trade represents a 0.12% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Company insiders own 0.30% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts have recently weighed in on the stock. JPMorgan Chase & Co. raised their price target on shares of CME Group from $266.00 to $271.00 and gave the stock an “underweight” rating in a research note on Thursday, April 16th. Raymond James Financial reaffirmed an “outperform” rating and set a $320.00 price objective on shares of CME Group in a research note on Thursday, July 2nd. Wall Street Zen downgraded shares of CME Group from a “hold” rating to a “sell” rating in a report on Sunday, July 12th. Deutsche Bank Aktiengesellschaft cut their price objective on shares of CME Group from $342.00 to $322.00 and set a “buy” rating for the company in a report on Thursday, April 23rd. Finally, TD Cowen lowered their target price on CME Group from $323.00 to $273.00 and set a “buy” rating on the stock in a report on Monday, June 22nd. Twelve research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $292.12.

CME Group News Roundup

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: CME Group posted Q2 adjusted earnings of $2.99 per share, topping estimates, while revenue of about $1.71 billion also beat forecasts. The upside was supported by strong hedging demand and active derivatives trading, which reinforced confidence in the company’s core exchange business. Reuters article
• Positive Sentiment: Management said the first half of 2026 was the strongest in company history for revenue, adjusted operating income, adjusted net income, and adjusted diluted EPS, suggesting momentum remains solid heading into the rest of the year. Quiver Quantitative article
• Positive Sentiment: Trading volumes were strong, with average daily volume near 29.8 million contracts and record market data revenue of $238 million, both of which support the view that CME is benefiting from elevated market activity and pricing power. Seeking Alpha presentation
• Positive Sentiment: Shares also gained support from unusual call-option buying and broader investor interest following the earnings beat, which can reinforce near-term upward momentum. Quiver Quantitative options flow article
• Neutral Sentiment: CEO Terrence Duffy pushed back on market chatter about potential perpetual-futures products, saying clients are not demanding them. That appears to have been a side issue rather than a direct driver of the move. Bloomberg article

CME Group Stock Performance

NASDAQ:CME opened at $249.24 on Thursday. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.02 and a quick ratio of 1.02. The firm has a market capitalization of $90.31 billion, a price-to-earnings ratio of 21.27, a PEG ratio of 2.95 and a beta of 0.25. The company’s 50-day moving average is $255.87 and its two-hundred day moving average is $281.51. CME Group Inc. has a 1-year low of $218.31 and a 1-year high of $329.16.

CME Group (NASDAQ:CME) last posted its quarterly earnings results on Wednesday, July 22nd. The financial services provider reported $2.99 earnings per share for the quarter, beating the consensus estimate of $2.91 by $0.08. The business had revenue of $1.71 billion during the quarter, compared to analysts’ expectations of $1.68 billion. CME Group had a net margin of 63.19% and a return on equity of 15.42%. The business’s revenue for the quarter was up .8% on a year-over-year basis. During the same quarter in the prior year, the company posted $2.96 EPS. Analysts forecast that CME Group Inc. will post 12.17 EPS for the current year.

CME Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, June 25th. Shareholders of record on Tuesday, June 9th were paid a dividend of $1.30 per share. The ex-dividend date of this dividend was Tuesday, June 9th. This represents a $5.20 annualized dividend and a yield of 2.1%. CME Group’s dividend payout ratio (DPR) is 44.37%.

CME Group Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.